Purchase Order N3239825P0403
Award Date
6/13/25
Potential Completion Date
4/3/26
Potential Value
$51K
Federal Agency
Bureau of Medicine and Surgery
Awardee
Biosearch Technologies, Inc.
Ultimate Awardee
Not listed
NAICS Category
334516 - Analytical Laboratory Instrument Manufacturing
PSC Category
6640 - Laboratory Equipment And Supplies
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Peru
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This $62,965.40 firm fixed price purchase order was awarded by the Bureau of Medicine and Surgery, a defense agency, to Biosearch Technologies, Inc.'s LGC Biosearch Technologies division. The contract is for the delivery of DLO-FB1-2 dual-labeled probe, with a completion date of July 31, 2025. Biosearch Technologies is a privately held company that specializes in the design, development, and manufacture of oligonucleotide-based tools. The company has a history of providing laboratory supplies,...
This is a firm fixed price purchase order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID) to Biosearch Technologies, Inc. LGC Biosearch Technologies Division. The contract, worth $6,489.45, is for the delivery of primers and oligonucleotides to support NIAID's research and diagnostic efforts. The contract has a total small business set-aside designation. Biosearch Technologies, a private company specializing in oligonucleotide-based tools, has previously...
This is a firm fixed price contract awarded by the Centers for Disease Control and Prevention (CDC) to Biosearch Technologies, Inc. for the delivery of primer probes. The contract is a Blanket Purchase Agreement (BPA) call valued at $626,838.00, with an ultimate completion date of July 30, 2022. Biosearch Technologies, through its LGC Biosearch Technologies division, is a privately held company that specializes in the design, development, and manufacture of oligonucleotide-based tools. This...
This federal contract award, valued at $249,997.00, was made by the Centers for Disease Control and Prevention (CDC) to Biosearch Technologies, Inc., a foreign-owned, for-profit manufacturer of oligonucleotide-based laboratory supplies and diagnostic testing components. The contract is for the provision of polymerase chain reaction (PCR) testing kits, with a period of performance running through April 24, 2025. Biosearch Technologies has a significant history as a federal contractor, having...
This federal contract award to Biosearch Technologies, Inc. LGC Biosearch Technologies Division, a privately held manufacturer of oligonucleotide-based tools, is for the provision of primers and probes. The $127,000.00 firm fixed price purchase order was issued by the Centers for Disease Control and Prevention (CDC) to support disease surveillance, diagnostic testing, public health research, and emergency response efforts related to pathogens such as influenza, COVID-19, Ebola, and Brucella....
This is a firm fixed-price purchase order contract awarded by the Centers for Disease Control and Prevention (CDC) to Biosearch Technologies, Inc., a privately held company specializing in oligonucleotide-based tools. The contract, valued at $87,500.00, is for the provision of laboratory equipment. Biosearch Technologies has a history of providing laboratory supplies such as primer probes, assay kits, PCR kits, and oligonucleotides to support the CDC, Department of Defense, and National...
The Department of Health and Human Services Centers for Disease Control and Prevention awarded a firm fixed price delivery order contract to Biosearch Technologies, Inc. LGC Biosearch Technologies Division. The $787,500.00 contract, which has no set-aside designation, is for the provision of oligonucleotide-based laboratory supplies such as primer probes, assay kits, PCR kits, and oligonucleotides. These products support the CDC's disease surveillance, diagnostic testing, public health research,...
This is a federal contract award to Biosearch Technologies, Inc. LGC Biosearch Technologies Division, a private company specializing in oligonucleotide-based tools. The contract, valued at $10,955.45, was awarded by the National Institute of Diabetes and Digestive and Kidney Diseases, a civilian agency, on a firm fixed price basis with no set-aside designation. The contract is for the provision of laboratory supplies such as primer probes, assay kits, PCR kits, and oligonucleotides to support...
This firm fixed-price purchase order was awarded by the Centers for Disease Control and Prevention (CDC), a component of the Department of Health and Human Services (HHS), to Biosearch Technologies, Inc. (dba Biosearch Technologies). The $473,206.40 contract is for the provision of a SARS-COV-2 Influenza Multiplex Assay, which supports disease surveillance, diagnostic testing, public health research, and emergency response efforts related to pathogens such as COVID-19. Biosearch Technologies,...
This is a firm fixed price delivery order contract awarded by the Centers for Disease Control and Prevention (CDC) to Biosearch Technologies, Inc. for $98,400.00. The contract, which has no set-aside designation, is for the provision of laboratory supplies such as primer probes, assay kits, PCR kits, and oligonucleotides to support disease surveillance, diagnostic testing, public health research, and emergency response efforts related to pathogens like influenza, COVID-19, Ebola, and Brucella....